Skip to main content

Table 3 Linear regression analysis of the association between CKD treatments and the serum CRP concentration #

From: Effect of erythropoietin-stimulating agent on uremic inflammation

Factor

Regression coefficient

95%CI

p value

ESA

−0.111

−0.274 - -0.065

0.0015

ESA dose

−0.117

−0.014 - -0.003

0.0017

ARB

−0.076

−0.196 - -0.012

0.0275

ACE-I

−0.061

−0.221 - 0.012

0.0785

ARB or ACE-I

−0.083

−0.212 - -0.022

0.0154

ARB and ACE-I

−0.065

−0.267 - 0.005

0.0589

CCB

−0.1

−0.241 - -0.046

0.0039

other anti-HT

−0.068

−0.188 - 0.001

0.0515

AT-120

−0.041

−0.190 - 0.046

0.2306

Vitamin D

−0.064

−0.220 - 0.007

0.0664

Fe

−0.086

−0.334 - 0.003

0.054

  1. # All factors are adjusted by the "duration of nephrologist care"
  2. ESA; erythropoietin-stimulating agents, ARB; angiotensin-II receptor blockers, ACE-I; angiotensin-converting enzyme inhibitors, CCB; calcium channel blockers, anti-HT; antihypertensive.